APIM Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Trondheim
Business model:B2B

APIM Therapeutics is an early stage therapeutic company, pursuing a novel approach for enhancing the efficacy of several currently used cancer therapies on multiple cancer indications. Specifically, APIM Therapeutics focuses on peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), an emerging cancer drug target implicated in the regulation of cellular responses to cellular stress and tumor evasion from therapy.

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.63M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to APIM Therapeutics

Name Criteria
Norway SonoClear
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sarsia Seed Management
  • Total raised in a similar range: 1M - 5M USD
Norway Zelluna Immunotherapy As
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Birk Venture, Ro Invest
Norway Inhbio
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: TeleVenture Management
Norway FunzioNano
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Investinor
  • Total raised in a similar range: 1M - 5M USD
Norway Nisonic
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Investinor
  • Total raised in a similar range: 1M - 5M USD
Norway Tellu IoT AS
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Investinor
  • Total raised in a similar range: 1M - 5M USD
Norway Spinchip Diagnostics
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Investinor
  • Total raised in a similar range: 1M - 5M USD
Norway Planktonic
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Investinor
  • Total raised in a similar range: 1M - 5M USD
Norway Hy5
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Investinor
  • Total raised in a similar range: 1M - 5M USD
Denmark Biograil
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Top